Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Clinical trial NCT02938520 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02938520
- Sponsor
- ViiV Healthcare
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-27
- Primary completion
- 2018-08-30
- Enrollment
- 631
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.